Real-world assessment of AR-LBD mutations in metastatic castration-resistant prostate cancer.

被引:0
|
作者
Antonarakis, Emmanuel S.
Zhang, Nicole
Saha, Jayati
Nevalaita, Liina
Shell, Scott A.
Garratt, Chris
Ikonen, Tarja
Fizazi, Karim
机构
[1] Univ Minnesota, Phys Oncol Clin, Minneapolis, MN USA
[2] Guardant Hlth Inc, Palo Alto, CA USA
[3] Guardant Hlth, Redwood City, CA USA
[4] Orion Corp, Orion Pharma, Espoo, Finland
[5] Orion Pharma, Nottingham, England
[6] Orion Pharma, Espoo, Finland
[7] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
204
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis
    Baijun Dong
    Bin Yang
    Wei Chen
    Xinxing Du
    Liancheng Fan
    Xudong Yao
    Wei Xue
    Medical Oncology, 39
  • [42] Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer
    Koguchi, Dai
    Tsumura, Hideyasu
    Tabata, Ken-ichi
    Shimura, Soichiro
    Satoh, Takefumi
    Ikeda, Masaomi
    Watanabe, Akinori
    Yoshida, Tsutomu
    Sasaki, Jiichiro
    Matsumoto, Kazumasa
    Iwamura, Masatsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (05) : 569 - 576
  • [43] Risk Factors for and Incidence of Seizures in Metastatic Castration-Resistant Prostate Cancer: A Real-World Retrospective Cohort Study
    Charles Dharmani
    Machaon Bonafede
    Andrew Krivoshik
    Clinical Drug Investigation, 2017, 37 : 1183 - 1190
  • [44] Prevalence and management of castration-resistant prostate cancer of unknown metastatic status in the real-world setting: The AfroDiTA study
    Rodrigo-Aliaga, Miguel
    Alvarez-Ossoriob, Jose L.
    Rodriguez-Alonsoc, Andres
    Garcia-Porrerod, Angela
    Quesada-Garciad, Alba
    del Torod, Jacobo Munoz
    Rodriguez-Antolin, Alfredo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (01) : 64e11 - 64e18
  • [45] Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis
    Dong, Baijun
    Yang, Bin
    Chen, Wei
    Du, Xinxing
    Fan, Liancheng
    Yao, Xudong
    Xue, Wei
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [46] Real-world management of metastatic castration-resistant prostate cancer (mCRPC): A national multicenter cohort study.
    Lavallee, Luke
    Morash, Chris
    Saad, Fred
    Yip, Steven
    Kapoor, Anil
    Kolinsky, Michael Paul
    Pouliot, Frederic
    Antebi, Elie
    Drachenberg, Darrel
    Ferrario, Cristiano
    Gotto, Geoffrey
    Hamilton, Robert James
    Ko, Jenny J.
    Noonan, Krista
    So, Alan
    Malone, Shawn
    Zardan, Anousheh
    Chi, Kim N.
    Hotte, Sebastien J.
    Niazi, Tamim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [47] Prevalence of castration-resistant prostate cancer (CRPC) of unknown metastatic status in the real-world setting: The AfrODiTA study
    Rodrigo-Aliaga, M.
    Alvarez-Ossorio, J. L.
    Rodriguez-Alonso, A.
    Garcia Garcia-Porrero, A.
    Quesada-Garcia, A.
    Munoz del Toro, J.
    Rodriguez-Antolin, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S646 - S646
  • [48] Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
    LI, Jian-ri
    Wang, Shian-shiang
    Chen, Chuan-shu
    Yang, Cheng-kuang
    Lu, K. E. V. I. N.
    Cheng, Chen-Li
    Hung, Sheng-Chun
    Chen, Shu-Yen
    Hsu, Chiann Yi
    Chiu, Kun-Yuan
    ANTICANCER RESEARCH, 2022, 42 (10) : 4857 - 4866
  • [49] Real-world data on metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: A regional experience
    Raju, R.
    Sahu, A.
    Klevansky, M.
    Torres, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1332 - S1332
  • [50] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)